Creatine May Shield Hippocampal Neurons from Gut Inflammation in Male Rats
A new study in Brain, Behavior, and Immunity finds that creatine supplementation prevents brain inflammation and neuronal damage in rats with chronic colitis. The protective effects were most pronounced in males, who suffered significant hippocampal cell loss and electrical dysfunction, while females remained largely unaffected at the cellular level. Although creatine is known as a workout supplement, it acts as a cellular energy reserve that may buffer the brain against inflammatory signals from the gut. The findings suggest a potential neuroprotective role for creatine in gut-related brain changes, though the study was conducted in rats and does not confirm efficacy in humans.
Key points
- Chronic colitis in rats triggered brain inflammation, activating microglia and elevating inflammatory molecules in the hippocampus.
- Male rats experienced severe neuronal damage, including loss of structural proteins and a 60% increase in the current required to fire neurons, whereas female rats maintained neuronal structure despite inflammation.
- Creatine supplementation, given at 1 gram per kilogram daily, restored hippocampal creatine levels and prevented microglia activation and inflammatory spikes in both sexes.
- In males, creatine protected neuronal structure and electrical resistance, while in females it specifically suppressed tumor necrosis factor, a key inflammatory marker.
- The study tested prevention rather than treatment, as creatine was administered before colitis was induced, and did not measure behavioral or memory outcomes.
Background
This research builds on a series of studies from the same team at the Universidad de Sevilla, including a 2024 report linking chronic colitis to memory problems and anxiety in rats, and a 2025 study showing creatine prevents cortical inflammation. It contrasts with recent 2026 archive reports questioning the cognitive benefits of other supplements like vitamin D and fish oil in aging humans, highlighting that supplement effects may vary by compound and condition. While the current study focuses on gut-brain inflammation, it does not address the broader debate on supplement safety in older adults.
Why it matters
The study provides mechanistic evidence that creatine may protect the brain from secondary inflammation caused by gut diseases, a link often cited in inflammatory bowel disease (IBD) but rarely tested at the cellular level. The stark sex differences in neuronal vulnerability suggest that future research must account for biological sex when evaluating neuroprotective strategies. However, the authors caution that these rat-based findings cannot be extrapolated to human treatment, and the small sample sizes for electrical tests may have masked subtle effects in females. The results underscore the need for human trials to determine if creatine can serve as a complementary strategy for IBD patients experiencing cognitive or mood issues.
What to watch
Researchers plan to investigate the specific molecular pathways through which creatine protects hippocampal neurons, particularly whether its role in cellular energy metabolism is central to the effect. Future studies will need to determine if these protective mechanisms apply to humans and whether creatine can be used as a complementary approach for individuals with chronic intestinal inflammation. Additionally, larger-scale studies are needed to assess behavioral and memory outcomes, as the current research focused solely on cellular and electrical metrics.
Want the full story? Read the original reporting
Read on PsyPost